InvestSMART

Raptor Metals Ltd (ASX: RAP) - Announcements

- Current share price for RAP : $0.014

ASX company news and announcements for Raptor Metals Ltd (RAP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Raptor Metals Ltd (RAP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Raptor Metals Ltd (RAP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Raptor Metals Ltd (RAP)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$6 Initial Director's Interest Notice 29 Dec 2017 9:41AM $0.074 $0.014 fallen by 81.08%
$6 ResApp Appoints Non-Executive Director 29 Dec 2017 9:32AM $0.074 $0.014 fallen by 81.08%
$6 ResApp Receives IRB Approval at Massachusetts General 19 Dec 2017 9:40AM $0.091 $0.014 fallen by 84.62%
$6 Appendix 3B 18 Dec 2017 7:54PM $0.091 $0.014 fallen by 84.62%
$6 Positive Results from Australian Adult Clinical Studies 18 Dec 2017 9:30AM $0.071 $0.014 fallen by 80.28%
$6 ResApp Receives IRB Approval at Texas Children's Hospital 13 Dec 2017 8:56AM $0.071 $0.014 fallen by 80.28%
$6 Results of Annual General Meeting 3 Nov 2017 1:35PM $0.078 $0.014 fallen by 82.05%
$6 AGM CEO and Managing Director's Address to Shareholders 3 Nov 2017 9:19AM $0.077 $0.014 fallen by 81.82%
$6 Appendix 4C - quarterly 16 Oct 2017 9:27AM $0.075 $0.014 fallen by 81.33%
$6 ResApp to Present at Upcoming Investor Conferences 10 Oct 2017 9:34AM $0.080 $0.014 fallen by 82.50%
$6 Change of Director's Interest Notice 6 Oct 2017 9:44AM $0.075 $0.014 fallen by 81.33%
$6 Notice of Annual General Meeting 3 Oct 2017 3:42PM $0.070 $0.014 fallen by 80%
$6 Letter to Shareholders 29 Sep 2017 5:40PM $0.067 $0.014 fallen by 79.10%
$6 Appendix 4G 29 Sep 2017 5:32PM $0.067 $0.014 fallen by 79.10%
$6 Annual Report 2017 29 Sep 2017 5:27PM $0.067 $0.014 fallen by 79.10%
$6 Becoming a substantial holder 22 Sep 2017 9:21AM $0.068 $0.014 fallen by 79.41%
$6 Updated Corporate Governance Policies 20 Sep 2017 9:42AM $0.073 $0.014 fallen by 80.82%
$6 Update on Field Evaluation by Medecins Sans Frontieres 14 Sep 2017 9:58AM $0.086 $0.014 fallen by 83.72%
$6 Investor Presentation 12 Sep 2017 9:04AM $0.082 $0.014 fallen by 82.93%
$6 SMARTCOUGH-C Study and Paediatric Clinical Strategy Update 4 Sep 2017 9:01AM $0.067 $0.014 fallen by 79.10%
$6 Appendix 4E - Preliminary Final Report 31 Aug 2017 4:21PM $0.063 $0.014 fallen by 77.78%
$6 Dr Philip Currie Joins ResApp's Scientific Advisory Board 23 Aug 2017 9:03AM $0.064 $0.014 fallen by 78.13%
$6 ResApp Receives R&D Tax Incentive Cash Refund for FY16 21 Aug 2017 9:23AM $0.068 $0.014 fallen by 79.41%
$6 Change of Director's Interest Notice 11 Aug 2017 9:13AM $0.100 $0.014 fallen by 86%
$6 Investor Conference Call 9 Aug 2017 4:24PM $0.070 $0.014 fallen by 80%

401 - 425 of 589 results

Page 17 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.